LEGN Legend Biotech Corp

$28.17

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Legend Biotech Corp

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in North America and internationally.

Website: https://www.legendbiotech.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1801198
Address
2101 COTTONTAIL LANE, SOMERSET, NJ, UNITED STATES
Valuation
Market Cap
$6.02B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
5.79
Performance
EPS
$-0.96
Dividend Yield
—
Profit Margin
-28.20%
ROE
-15.40%
Technicals
50D MA
$35.23
200D MA
$42.92
52W High
$60.87
52W Low
$29.27
Fundamentals
Shares Outstanding
184M
Target Price
$77.99
Beta
0.21

LEGN EPS Estimates vs Actual

● Estimated
● Actual

LEGN News & Sentiment

Nov 13, 2025 • Benzinga SOMEWHAT-BULLISH
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia - Legend Biotech ( NASDAQ:LEGN )
31,000-square-foot site expands Legend's U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation The facility will support CAR-T R&D in potential oncology and immunology indications
Nov 13, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
31,000-square-foot site expands Legend's U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation ...
Nov 13, 2025 • Zacks Commentary NEUTRAL
Company News for Nov 13, 2025
Companies in The News Are: LEGN, ONON, PLTR, ALC ...
Nov 03, 2025 • GlobeNewswire NEUTRAL
Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology ( ASH ) Annual Meeting
Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma ...
Nov 03, 2025 • Benzinga NEUTRAL
Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology ( ASH ) Annual Meeting - Legend Biotech ( NASDAQ:LEGN )
Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session
Oct 21, 2025 • Zacks Commentary SOMEWHAT-BULLISH
CorMedix ( CRMD ) Surges 19.5%: Is This an Indication of Further Gains?
CorMedix (CRMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Sentiment Snapshot

Average Sentiment Score:

0.102
50 articles with scored sentiment

Overall Sentiment:

Neutral

LEGN Reported Earnings

Aug 11, 2025
Jun 30, 2025 (Pre market)
0.15 Surprise
  • Reported EPS: $0.03
  • Estimate: $-0.12
  • Whisper: —
  • Surprise %: 125.0%
May 13, 2025
Mar 31, 2025 (Pre market)
-0.29 Surprise
  • Reported EPS: $-0.54
  • Estimate: $-0.25
  • Whisper: —
  • Surprise %: -112.6%
Mar 11, 2025
Dec 31, 2024 (Pre market)
0.52 Surprise
  • Reported EPS: $0.14
  • Estimate: $-0.38
  • Whisper: —
  • Surprise %: 137.2%
Nov 12, 2024
Sep 30, 2024 (Pre market)
-0.26 Surprise
  • Reported EPS: $-0.68
  • Estimate: $-0.42
  • Whisper: —
  • Surprise %: -62.8%
Aug 09, 2024
Jun 30, 2024 (Pre market)
0.28 Surprise
  • Reported EPS: $-0.10
  • Estimate: $-0.38
  • Whisper: —
  • Surprise %: 73.7%
May 13, 2024
Mar 31, 2024 (Pre market)
0.18 Surprise
  • Reported EPS: $-0.16
  • Estimate: $-0.34
  • Whisper: —
  • Surprise %: 52.9%
Mar 11, 2024
Dec 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.80
  • Estimate: $-0.83
  • Whisper: —
  • Surprise %: 3.6%
Nov 20, 2023
Sep 30, 2023 (Pre market)
0.34 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.68
  • Whisper: —
  • Surprise %: 50.0%
Aug 15, 2023
Jun 30, 2023 (Pre market)
-0.54 Surprise
  • Reported EPS: $-1.14
  • Estimate: $-0.60
  • Whisper: —
  • Surprise %: -90.0%

Financials